User:Mr. Ibrahem/Valbenazine

Valbenazine, sold under the trade name Ingrezza, is a medication used to treat tardive dyskinesia, a long term movement disorder due to antipsychotics. It is taken by mouth. Long term use is required.

Common side effects include dry mouth, sleepiness, urinary retention, dizziness, and headache. Other side effects include QT prolongation. Use is not recommended in those with severe kidney problems. It is a vesicular monoamine transporter 2 (VMAT2) inhibitor.

Valbenazine was approved for medical use in the United States in 2017. As of 2018 it costs 5,750 to 6,225 USD per month. It is only available at certain pharmacies. There is not currently plans to sell it in Europe as of 2018.